New Resource
UAMS Research Dashboard
An interactive reporting tool designed to provide comprehensive visibility into extramural awards, proposals, and publications across the institution.
View DashboardRecent Awards
Congratulations to our investigators on receiving their awards!
Arkansas INBRE Renewed for 5 Years Through 04/30/2031.
The $19.6M award supports UAMS, UA Fayetteville, UALR, and partners mentoring 16 undergrad institutions since 2001, growing biomedical research statewide.
Clinician Research Education and Scientific Training (CREST) Program
Drs. William Steinbach, Sara Shalin, and Mark Smeltzer received an NIH award totaling ~$2.8 million for the CREST Program, 07/01/2026 – 06/30/2031.
Melda Onal, PhD
Dr. Melda Onal received an NIH award totaling ~$2.4 million for “Role of Autophagy in Skeletal Diseases,” 06/01/2026 – 03/31/2031.
Awards
Fenghuang Zhan, MD, PhD
Dr. Fenghuang Zhan received an NIH renewal award totaling ~$2.5 million for drug-resistant genes in multiple myeloma research, 06/01/2020 – 05/31/2031.
Samantha Kendrick, PhD
Dr. Samantha Kendrick received an NIH renewal award totaling $794,599 for the PCAR Program, 09/01/2020 – 04/30/2031.
Yong-Chen Lu, PhD
Dr. Yong-Chen Lu received a Department of War award totaling $559,998 for immunotherapy for acral lentiginous melanoma targeting ROPN1B, 06/01/2026 – 05/31/2028.
Impact of new federal funding decisions on UAMS research activity
Research News
Funding Renewed for UAMS-led Biomedical Research Program, Bringing INBRE’s 30-Year-Total to More Than $107 Million
LITTLE ROCK — A federal grant that funds Arkansas INBRE, a statewide biomedical research program led by the University of Arkansas for Medical Sciences (UAMS), has been extended for another five years, providing 30 years of continuous funding totaling more than $107 million. The latest grant from the National Institute of General Medical Sciences, which…
Read more
College Students Gain Understanding of Substance Use Through INBRE Workshop
Thirty college students from across the country recently gathered at the University of Arkansas for Medical Sciences to learn about one of medicine’s most pressing challenges, the opioid crisis.
Read more
Mitch McGill, Ph.D., Is Part of Research Group Examining Liver Safety Biomarker
Mitch McGill, Ph.D., faculty at the University of Arkansas for Medical Sciences (UAMS), is part of a nationwide collaboration that recently succeeded in obtaining FDA acceptance of a new biomarker, dehydrogenase (GLDH) biomarker. Glutamate dehydrogenase is an enzyme located primarily in the liver. According to the United States Food and Drug Administration (FDA), a biomarker…
Read more
UAMS Drug Discoveries, Emerging Therapies Highlighted at Research Showcase
Advances at the University of Arkansas for Medical Sciences (UAMS) in developing next-generation treatments for cancer, infectious diseases, retinal injury, and more were the focus of the May 13 Showcase of Medical Discoveries.
Read moreWant to read more stories like these?
Past Research and Innovation Seminars
Seminar Series on Grantsmanship, Research Administration, Grants Management, and Regulatory Affairs
Click to View Archived Seminars